Regulatory Landscape Newsletter – August 2023

This is our Regulatory Landscape newsletter for August 2023 with our monthly insights on the evolving market for regulatory professionals.   

For the month of July there were only about 70 new Regulatory positions posted at smaller biotech and pharma companies in the US. This is down 22% from last month but consistent with what we usually see in July.  

About 65% of these positions were in Clinical Regulatory Strategy and 23% were in CMC Regulatory, 6% were in Advertising, Promotions & Labeling, and 6% in Regulatory Operations.  The majority of these roles were at Director level and above. There were six new Regulatory VP/SVP positions posted in July. There are now approximately 30 open VP/SVP Regulatory roles across the country.   

About 23% of all new Regulatory roles in July were posted as Remote and about 19% were Hybrid (remote/onsite), consistent with the previous month. There were layoffs announced at 24 biotech and pharma companies in July. This is the most we have seen so far this year.   

You can view a case study regarding a SVP of Regulatory and Quality role we recently filled in 60 days, along with several other case studies here:  https://dennispartners.com/case-studies/

This month we are helping our client to find a Regulatory Affairs Senior Director or Executive in the SF Bay Area and you can see the job description here:  https://dennispartners.com/jobs/regulatory-affairs-senior-director-or-executive-director/ 

Please keep us in mind if you need assistance with your Regulatory hiring or let us know if you are open to making a career move soon.